5.510USDMkt Cap: —P/E: —10d ago
CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company offers Unyvero appl…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value69.96M $
Revenue (TTM)30.20M $
Gross Profit27.18M $
Net Income (TTM)23.18M $
Revenue/Share2.872 USD
Last Price5.510 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINUS68373L4068
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA2.92
EV/Revenue2.32
P/S—
P/B2.18
EPS (TTM)—
EPS (Forward)—
52W Range
4.010100% of range5.510
52W High5.510 USD
52W Low4.010 USD
Profitability
Gross Margin90.00%
Oper. Margin78.63%
EBITDA Margin79.28%
Profit Margin77.21%
ROE121.73%
ROA63.33%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.44M $
CapEx (TTM)—
FCF Margin66.67%
FCF Yield—
Net Debt1.72M $
Net Debt/EBITDA0.07
Balance Sheet
Debt/Equity5.76
Current Ratio0.10
Quick Ratio0.07
Book Value/Sh2.527 USD
Cash/Share0.0060 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.1:1
Split DateMay 20, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float3.87M
Insiders85.50%
Institutions0.00%
Technical
SMA 500.4152 (+1227.0%)
SMA 2000.4475 (+1131.2%)
Beta-2545.04
S&P 52W Chg20.80%
Avg Vol (30d)5
Avg Vol (10d)2.74K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—